Brief: Aptevo Therapeutics Announces Details On Preclinical Bispecific Antibody APVO442
04/12/2024 13:53
Dec 4 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC - ANNOUNCES DETAILS ON PRECLINICAL
BISPECIFIC ANTIBODY APVO442
Source text: ID:n0000950170-24-133091
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary